Nottingham Joins £50M Cardiovascular Inequality Consortium: A Step Towards Health Equity
The University of Nottingham has joined forces with a national consortium to address the stark disparities in cardiovascular disease (CVD) outcomes across the UK. Funded by a substantial £50 million investment from the National Institute for Health and Care Research (NIHR), this initiative aims to tackle the systemic inequalities in CVD, which claims a quarter of all lives in the UK (over 170,000 annually).
The consortium, comprising the University of Nottingham, King's College London, Lambeth Council, and Boots, is committed to developing innovative community-based solutions. These approaches aim to improve access to cardiovascular care for underserved populations, particularly those from ethnic minority communities and deprived areas. By addressing the root causes of these disparities, the consortium seeks to deliver early interventions and enhance the quality of care for all.
Professor Nadeem Qureshi, a key figure in this project, emphasizes the need for sustainable, community-grounded strategies. He states, 'Primary care has traditionally provided established cardiovascular checks, but these services often fail to reach those who need them most. This consortium presents an opportunity to develop more inclusive and effective models of care, ensuring early detection of high blood pressure and cholesterol levels for underserved populations.'
The consortium's focus extends beyond clinical settings. It aims to collaborate with various organizations, including charities, social enterprises, local councils, NHS Trusts, and industry, to drive system-wide change. By working together, they will generate evidence-based solutions to improve the detection and management of undiagnosed or poorly controlled hypertension and hypercholesterolemia, potentially saving thousands of lives.
The project will also prioritize research capacity development, fostering the next generation of researchers. This includes creating career development opportunities to inspire, mentor, and support aspiring scientists. The research projects are set to commence in autumn 2026, with a strong emphasis on building relationships with relevant stakeholders, such as charities, the life sciences industry, and patient groups.
The consortium's success hinges on a multi-faceted approach, leveraging wearables and digital health technologies, and implementing innovative public health messaging and education. This comprehensive strategy aims to support sustained behavior change, ultimately reducing health inequalities in the UK.
Professor Lucy Chappell, Chief Scientific Adviser at the Department of Health and Social Care (DHSC) and CEO of the NIHR, highlights the significance of this initiative, stating, 'Cardiovascular disease remains a leading cause of death in the UK, with a substantial long-term burden on the NHS. However, with early intervention, it can be preventable. This ambitious investment from the NIHR is a pivotal step towards addressing the root causes of health inequalities, one of the nation's most pressing challenges.'
The consortium's impact will be far-reaching, benefiting populations across the UK, including rural and coastal communities, as well as urban-deprived areas. By collaborating with leading universities and organizations, this initiative has the potential to revolutionize cardiovascular care and significantly reduce health disparities.
